The Bloomberg-Kimmel Institute for Cancer Immunotherapy was founded in large part with gifts from two longstanding Johns Hopkins champions: Michael R. Bloomberg and Sidney Kimmel.Read about our donors and what drives their philanthropy.
We support cancer immunology research across many cancer types.
We emphasize research aimed at impacting cancer care and clinical trials. Our multidisciplinary team is probing the vast potential of the immune system.
We are developing precision-based approaches that treat genetic subsets of cancer patients with the specific immunotherapy — or a combination of immunotherapy and other treatments — most likely to succeed.